A meta-analysis indicated that antinuclear autoantibodies (ANAs) including anti-gp210 and anti-sp100 were found in 30%-50% of patients with PBC [18] but did not specifically address their diagnostic performances for AMA-negative PBC. This evidence concerns the gene SP100 and primary biliary cholangitis.